Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 8 of 8 entries
View as:

Study of Tesomet With Open-label Extension in Subjects With Prader-Willi Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT05198362 Org: User:
Start: 12/28/21 End: 12/09/22 Due: 12/09/23

Co-administration of Tesofensine/Metoprolol in Subjects With Prader-Willi Syndrome (PWS)

Phase: N/A Priority: Normal
NCT ID: NCT03149445 Org: User:
Start: 03/30/17 End: 07/22/19 Due: 07/22/20

First-in-human Study of SAN711 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04971135 Org: User:
Start: 06/30/21 End: 06/30/22 Due: 06/30/23

48 Weeks, Study to Evaluate Overall Safety and Tolerability of Co-administration of Tesofensine and Metoprolol in Subjects With Hypothalamic Injury-induced Obesity (HIO)

Phase: N/A Priority: Normal
NCT ID: NCT03845075 Org: User:
Start: 02/25/19 End: 10/16/20 Due: 10/16/21

Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02737891 Org: User:
Start: 04/30/16 End: 03/31/17 Due: 03/31/18

Study to Investigate the Pharmacokinetic Profile

Phase: N/A Priority: Normal
NCT ID: NCT03286829 Org: User:
Start: 12/18/17 End: 02/06/18 Due: 02/06/19

Study of Tesomet With Open-label Extension in Subjects With Hypothalamic Obesity (HO)

Phase: N/A Priority: Normal
NCT ID: NCT05147415 Org: User:
Start: 11/11/21 End: 12/09/22 Due: 12/09/23

A Study to Examine the Effect of Tesofensine and Metoprolol on the 24-hour Mean Heart Rate

Phase: N/A Priority: Normal
NCT ID: NCT03488719 Org: User:
Start: 07/11/18 End: 06/06/19 Due: 06/06/20